Analysts expect BIO-TECHNE Corp to report revenue of 300.31 M for Q1 27, against a range of 279.41 M to 321.21 M. The most recent reported quarter, Q4 26, came in at 321.19 M, a 4.6% beat against the 306.97 M consensus.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 289.46 M | 297.03 M | 316.18 M | 316.96 M | 286.56 M | 295.88 M | 311.42 M | 321.19 M | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | 326.28 M | 300.14 M | 354.82 M | 358.60 M | 306.64 M | 282.50 M | 326.10 M | 324.74 M | 321.21 M | 341.41 M | 366.58 M | 347.11 M | 367.66 M | 368.44 M | 372.85 M | 422.86 M | ||||||||||||
| Low Estimate | 271.33 M | 247.70 M | 320.25 M | 307.98 M | 251.18 M | 262.77 M | 285.27 M | 289.21 M | 279.41 M | 293.56 M | 320.76 M | 286.66 M | 308.81 M | 326.70 M | 329.27 M | 354.48 M | ||||||||||||
| Consensus Estimate | 298.80 M | 273.92 M | 337.53 M | 333.29 M | 278.91 M | 272.63 M | 305.69 M | 306.97 M | 300.31 M | 317.48 M | 343.67 M | 316.88 M | 338.24 M | 347.57 M | 351.06 M | 388.67 M |
Analysts expect BIO-TECHNE Corp to report earnings per share of 0.47 for Q1 27, against a range of 0.44 to 0.50. The most recent reported quarter, Q4 26, came in at 0.52, a 4.0% beat against the 0.50 consensus.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.42 | 0.42 | 0.56 | 0.53 | 0.42 | 0.46 | 0.53 | 0.52 | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | 0.43 | 0.42 | 0.54 | 0.56 | 0.48 | 0.49 | 0.59 | 0.54 | 0.50 | 0.49 | 0.63 | 0.62 | 0.55 | 0.61 | 0.72 | 0.71 | ||||||||||||
| Low Estimate | 0.37 | 0.38 | 0.44 | 0.46 | 0.40 | 0.41 | 0.53 | 0.46 | 0.44 | 0.45 | 0.55 | 0.58 | 0.49 | 0.55 | 0.60 | 0.63 | ||||||||||||
| Consensus Estimate | 0.40 | 0.40 | 0.49 | 0.51 | 0.44 | 0.45 | 0.56 | 0.50 | 0.47 | 0.47 | 0.59 | 0.60 | 0.52 | 0.58 | 0.66 | 0.67 |
Pull Wall Street consensus for BIO-TECHNE Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TECH&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TECH", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=TECH&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();